Researchers from the University of California have discovered positive effects of testosterone gel on men suffering from multiple sclerosis (MS). Research involved 10 MS patients in the relapsing-remitting phase, with an annual decrease in brain size of 0.81%. These MS patients were given daily applications of the gel, containing 100 milligrams of testosterone, over 12 months. Inferences from the study showed a slower brain atrophy of 0.25% a year, with an average increase of 1.7 kg in muscle mass during the treatment, and reported no adverse effects. Further research might suggest the usage of testosterone gel in non-inflammatory neurodegenerative diseases.
A study published in the scientific journal of the ‘American Academy of Neurology’, by researchers from the University of Iowa and College of Medicine, Iowa, discussed early signs that could help doctors predict the incidence of Huntington's disease in human beings. The researchers selected 218 people, with a family history of Huntington's disease. The research involved testing the movement and cognitive and verbal ability of the participants for 4.5 years. The results from the tests showed a marked decrease in the level of psychomotor speed, putting the people at a higher risk factor of developing Huntington’s disease within three years.
A study published by the ‘American Academy of Neurology’ in the journal ‘Neurology’ reportedly suggests getting an epidural steroid injection for improvement in sciatic pain. The study administered two groups of sciatic patients with placebo and epidural steroid injection. The results from the treatment with epidural injection showed a decrease in sciatic pain between two and six weeks. However, the reports claim that epidural injection did not relieve the sciatic patients from back pain.
Powered by Qumana